Pacira Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
68.82
|
|
Average Rating
|
4.09
|
|
# Strong Buys
|
3
|
|
# Buys
|
6
|
|
# Holds
|
2
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
0.76
|
0.64
|
-0.12
|
-15.79%
|
|
2022-06-30
|
0.85
|
0.51
|
-0.34
|
-40.00%
|
|
2022-03-31
|
0.83
|
0.64
|
-0.19
|
-22.89%
|
|
2021-12-31
|
0.90
|
0.97
|
0.07
|
7.78%
|
|
2021-09-30
|
0.65
|
0.72
|
0.07
|
10.77%
|
|
2021-06-30
|
0.74
|
0.77
|
0.03
|
4.05%
|
|
2021-03-31
|
0.64
|
0.53
|
-0.11
|
-17.19%
|
|
2020-12-31
|
0.81
|
0.87
|
0.06
|
7.41%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
1.79
|
|
2021-12-31
|
2.99
|
|
2020-12-31
|
2.20
|
|
2019-12-31
|
1.67
|
|
2018-12-31
|
1.04
|
|
2017-12-31
|
0.19
|
|
2016-12-31
|
0.62
|
|
2015-12-31
|
0.95
|
|
2014-12-31
|
0.01
|
|
2013-12-31
|
-1.93
|
|
2012-12-31
|
-1.69
|
|
2011-12-31
|
-2.62
|